Product image of Fanhdi (Human Coagulation Factor Viii) supplied by GNH India

Fanhdi

Active Ingredient:
Human Coagulation Factor Viii
Origin:
EU

Fanhdi (Human Coagulation Factor Viii)

Fanhdi is a human coagulation factor VIII used for intravenous administration. It aids in blood clotting and is essential for managing certain bleeding disorders. This product is manufactured by Instituto Grifols, S.A. in the EU.

Manufacturer / TM Owner

Instituto Grifols, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fanhdi is primarily used to manage bleeding episodes in individuals with hemophilia A, a condition characterized by a deficiency in factor VIII. It helps to replace the missing clotting factor, thereby promoting normal blood clotting. This medication is also used to prevent bleeding during surgical procedures in patients with hemophilia A.

Side Effects

  • Common effects of Fanhdi may include mild reactions at the injection site, such as redness or swelling. Some individuals might experience flu-like symptoms, including fever or chills. Severe allergic reactions are rare but possible and require immediate medical attention.

Precautions & Warnings

  • Fanhdi should be handled with care and stored as per the manufacturer's instructions to maintain its efficacy. It is crucial to use this medication under the supervision of a healthcare professional. Patients should inform their healthcare provider about any known allergies or medical conditions before administration.

Avoid Interactions

  • Fanhdi may interact with certain medications, including those that affect blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect blood clotting should be used with caution.

Frequently Asked Questions

Fanhdi is used to manage bleeding episodes and prevent bleeding during surgery in individuals with hemophilia A.

Fanhdi is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include mild reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Fanhdi is specifically indicated for individuals with hemophilia A. Its use should be discussed with a healthcare provider.

Fanhdi should be stored as per the manufacturer's instructions to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT